Chordoma and Chondrosarcoma of the Skull Base and Spine

Status: draft · Last updated 2026-11-17 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • Chordoma is rare in children (under 5%), mostly cranial, with more metastases at presentation but longer survival than adults .
  • Worse prognosis:
    • under 10 years;
    • dedifferentiated, chondroid or poorly differentiated (INI1-lost) histology .
  • TSC-associated chordoma: infants, often sacral; 3 of 4 sacral cases were alive and tumor-free .
  • Treatment:
    • maximal safe resection (GTR or en bloc where feasible), then high-dose protons (about 70–75 Gy(RBE)) ;
    • biopsy alone does worse .
  • Conventional pediatric spinal chordoma after surgery and protons: about 94% overall survival at 20 years .
  • Chondrosarcoma: off-midline petroclival; after surgery (mostly subtotal) plus protons, 10-year overall survival was about 93% across the whole cohort .

Chordoma arises from notochordal remnants. It is rare in children: fewer than 5% of chordomas occur in childhood .

Chondrosarcoma is a cartilaginous malignancy that mimics chordoma at the skull base, but typically arises off the midline.

Both are treated the same way :

Jason S. Hauptman, MD, PhD© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure from Hauptman's High Yield Thoughts in Pediatric Neurosurgery (pedsneurosurg.org). Do not copy, reproduce, redistribute or adapt without written permission.https://www.pedsneurosurg.org/hy-peds-ns:chordoma_chondrosarcoma:239736f3ecfbe9ba© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure; please do not copy, reproduce or redistribute without written permission.Midsagittal skull base with a lobulated clival chordoma indenting the pons and extending toward C1 and the dens, a projected petroclival chondrosarcoma, and an endoscopic endonasal corridor inset; an axial cervical chordoma with the vertebral artery at risk, a sagittal sacral chordoma and en bloc versus intralesional margins; and brachyury and INI1-loss pathology(A) SKULL BASE (MIDSAGITTAL)pituitary in the sellasphenoid sinuspetroclival chondrosarcoma(off-midline, projected)indents the pons via theprepontine cisternclival chordoma: lobulated,midline, destroys the clivustoward C1 and the densnasopharynxendoscopic endonasalcorridor: nose, sphenoid,clivus(B) SPINEcervical chordoma (axial)vertebral arteryat riskbody destroyedepidural extensionparaspinal soft tissuesacral chordoma (sagittal)presacral massrectumL5sacrumen bloc marginintact, with a cuff ofnormal tissueintralesional (piecemeal)(C) PATHOLOGY MARKERSbrachyury: brown nuclearstaining (chordoma);physaliferous, bubbly cellsin myxoid matrixSMARCB1/INI1 loss = poorlydifferentiated chordoma(young children); tumor nucleinegative, vessels positiveabout 70-75 Gy(RBE)protonsafter maximal resection
Chordoma and chondrosarcoma. (a) Midsagittal skull base: midline clival chordoma extending into the prepontine cistern and indenting the pons, with a craniocervical-junction extension; separately, an off-midline petroclival chondrosarcoma (projected) at the petro-occipital synchondrosis. (b) Spine: chordoma of a cervical vertebral body extending into the epidural space and paraspinal soft tissue, and a sacral chordoma; en bloc resection margins versus intralesional resection. (c) Pathology markers: brachyury nuclear staining (chordoma) and SMARCB1/INI1 loss (poorly differentiated chordoma). Not to scale.

Chordoma in children: what's different

Diagnosis

Skull base chordoma

Spinal and sacral chordoma and chondrosarcoma

Chondrosarcoma

Radiotherapy

Related topics

References

  1. McMaster ML, Goldstein AM, Parry DM. Clinical features distinguish childhood chordoma associated with tuberous sclerosis complex (TSC) from chordoma in the general paediatric population. J Med Genet 2011;48(7):444–449. doi:10.1136/jmg.2010.085092. PMID 21266383. verified
  2. Radaelli S, Frezza AM, Fossati P, et al. Global consensus on the management of primary localized chordoma. JAMA Oncol 2026;12(9):1018–1026. doi:10.1001/jamaoncol.2026.2054. PMID 42424068. verified
  3. Vazquez M, Cherchik A, de Angelis C, et al. Long-term clinical outcome and quality of life of children, adolescents, and young adults with chordoma or chondrosarcoma treated with pencil beam scanning proton therapy. Pediatr Blood Cancer 2025;72(10):e31898. doi:10.1002/pbc.31898. PMID 40682267. verified
  4. Ioakeim-Ioannidou M, Goldberg S, Urell T, et al. Proton-based radiation therapy for skull base chondrosarcomas in children and adolescents: 40-year experience from the Massachusetts General Hospital. Int J Radiat Oncol Biol Phys 2025;121(2):403–413. doi:10.1016/j.ijrobp.2024.09.030. PMID 39303998. verified
  5. Lau CS, Mahendraraj K, Ward A, Chamberlain RS. Pediatric chordomas: a population-based clinical outcome study involving 86 patients from the Surveillance, Epidemiology, and End Result (SEER) database (1973–2011). Pediatr Neurosurg 2016;51(3):127–136. doi:10.1159/000442990. PMID 26881831. verified
  6. Clementi EA, Timothee P, Charles-Obi K, et al. Pediatric head and neck chordomas: a national analysis of prognostic indicators and survival outcomes. Otolaryngol Head Neck Surg 2026;174(2):522–530. doi:10.1002/ohn.70066. PMID 41252601. verified
  7. Duan Z, Feng J, Wang H, et al. Comprehensive profiling of paediatric chordoma: poorly differentiated and conventional subtypes. Brain Commun 2026;8(3):fcag207. doi:10.1093/braincomms/fcag207. PMID 42293322. verified
  8. Rassi MS, Hulou MM, Almefty K, et al. Pediatric clival chordoma: a curable disease that conforms to Collins' law. Neurosurgery 2018;82(5):652–660. doi:10.1093/neuros/nyx254. PMID 28521059. verified
  9. Bai J, Zhang S, Zhai Y, et al. A series of 62 skull base chordomas in pediatric and adolescent patients: clinical characteristics, treatments, and outcomes. Neurol India 2020;68(5):1030–1036. doi:10.4103/0028-3886.294548. PMID 33109847. verified
  10. Ioakeim-Ioannidou M, Niemierko A, Mukhammadov T, et al. Long-term outcomes following proton-based radiation therapy for pediatric chordomas and chondrosarcomas of the mobile spine and the sacrum. Int J Radiat Oncol Biol Phys 2025;123(1):63–73. doi:10.1016/j.ijrobp.2025.03.075. PMID 40204245. verified

Verification (2026-11-17):

Caveats: